Clinical Study
Value of Fused 18F-Choline-PET/MRI to Evaluate Prostate Cancer Relapse in Patients Showing Biochemical Recurrence after EBRT: Preliminary Results
Table 2
Patient-based analysis. DR was calculated for each single diagnostic modality in each site of disease.
| Site of disease
(number of patients considered) | mMRI |
18F-Choline-PET/MRI | CeCT |
18F-Choline-PET/CT |
18F-Fluoride-PET/MRI |
| | Local (21) | 6/21 (28%) | 6/21 (28%) | 1/21 (5%) | 4/21 (19%) |
— | | Lymph nodes (21) | 5/21 (24%) | 6/21 (28%) | 5/21 (24%) | 6/21 (28%) | — | | Bones of the pelvis (21) | 6/21 (28%) | 6/21 (28%) | 3/21 (14%) | 6/21 (28%) | 6/21 (28%) | | Cumulative DR (21) | 17/21 (81%) | 18/21 (86%) | 9/21 (43%) | 16/21 (76%) | 6/21 (28%) | | Bone (9) | — | — | 4/9 (44%) | 8/9 (89%) | 9/9 (100%) |
|
|
